DUBE ERIC M (Chief Executive Officer) sold 48.0% of their position (400K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $25.39M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+95.67K
Price / share
$23.34
Trade value
$2.23M
% of position
Common Stock
Shares
−63.50K
Price / share
$61.99
Trade value
$3.94M
% of position
Common Stock
Shares
−28.80K
Price / share
$62.66
Trade value
$1.80M
% of position
Common Stock
Shares
−3.10K
Price / share
$63.64
Trade value
$197.42K
% of position
Common Stock
Shares
−270.00
Price / share
$65.31
Trade value
$17.63K
% of position
Common Stock
Shares
+195.84K
Price / share
$23.34
Trade value
$4.57M
% of position
Common Stock
Shares
−99.72K
Price / share
$63.26
Trade value
$6.31M
% of position
Common Stock
Shares
−96.13K
Price / share
$63.64
Trade value
$6.12M
% of position
Common Stock
Shares
+108.49K
Price / share
$23.34
Trade value
$2.53M
% of position
Common Stock
Shares
−101.69K
Price / share
$64.59
Trade value
$6.57M
% of position
Common Stock
Shares
−6.80K
Price / share
$64.95
Trade value
$441.80K
% of position
Net shares
+0.00
Net value
-$16.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +95.67K | $23.34 | $2.23M | 22.1% | 432.89K | 528.55K |
| Common Stock Direct | 9/15/2026 | S · Sale | −63.50K | $61.99 | $3.94M | 12.0% | 528.55K | 465.05K |
| Common Stock Direct | 9/15/2026 | S · Sale | −28.80K | $62.66 | $1.80M | 6.2% | 465.05K | 436.26K |
| Common Stock Direct | 9/15/2026 | S · Sale | −3.10K | $63.64 | $197.42K | 0.7% | 436.26K | 433.16K |
| Common Stock Direct | 9/15/2026 | S · Sale | −270.00 | $65.31 | $17.63K | 0.1% | 433.16K | 432.89K |
| Common Stock Direct | 9/16/2026 | M · Option Exercise | +195.84K | $23.34 | $4.57M | 45.2% | 432.89K | 628.73K |
| Common Stock Direct | 9/16/2026 | S · Sale | −99.72K | $63.26 | $6.31M | 15.9% | 628.73K | 529.01K |
| Common Stock Direct | 9/16/2026 | S · Sale | −96.13K | $63.64 | $6.12M | 18.2% | 529.01K | 432.89K |
| Common Stock Direct | 9/17/2026 | M · Option Exercise | +108.49K | $23.34 | $2.53M | 25.1% | 432.89K | 541.38K |
| Common Stock Direct | 9/17/2026 | S · Sale | −101.69K | $64.59 | $6.57M | 18.8% | 541.38K | 439.69K |
| Common Stock Direct | 9/17/2026 | S · Sale | −6.80K | $64.95 | $441.80K | 1.5% | 439.69K | 432.89K |
| Total | +0.00 | -$16.05M | ||||||
Employee stock option (right to buy)
Common Stock
95.67K shares
Shares
−95.67K
Strike price
23.34
Held after
304.33K
Exercisable
—
Employee stock option (right to buy)
Common Stock
195.84K shares
Shares
−195.84K
Strike price
23.34
Held after
108.49K
Exercisable
—
Employee stock option (right to buy)
Common Stock
108.49K shares
Shares
−108.49K
Strike price
23.34
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock95.67K shares | 9/15/2026 | M · Option Exercise | −95.67K | 23.34 | — | 304.33K |
| Employee stock option (right to buy) Direct | Common Stock195.84K shares | 9/16/2026 | M · Option Exercise | −195.84K | 23.34 | — | 108.49K |
| Employee stock option (right to buy) Direct | Common Stock108.49K shares | 9/17/2026 | M · Option Exercise | −108.49K | 23.34 | — | 0.00 |